Table 2.
Randomized trials of adjuvant chemo or chemoradiotherapy in resected gastric cancer
Ref. | n | Regimen | 3 yr Disease free survival rate (%; P value) |
Lee et al[41], 2012 | 458 | XP vs XP/XRT/XP | No significant Disease free survival difference |
Yu et al[45], 2012 | 68 | 5FU/LV vs 5FU /LV/RT | 44.1 vs 67.7 (P < 0.05) |
Kim et al[44], 2012 | 90 | 5FU/LV vs 5FU/LV/RT | No significant Disease free survival difference |
Kwon et al[46], 2010 | 61 | 5FU/LV vs 5FU/LV/RT | No significant Disease free survival difference |
Bamias et al[43], 2010 | 147 | DP vs DP/RT | No significant Disease free survival difference |
X: Capecitabine; 5-FU: 5-fluorouracil; LV: Leucovorin; P: Cisplatin; D: docetaxel; RT: Radiotherapy (45 Gy).